BG-34-200

N/A

Report date: 2025/06/11 10:22:29
NME

Base Information

Drug NameBG-34-200
Drug Alias NameN/A
ClassificationSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionIntegrin alpha-M modulatorsImmunostimulantsMacrophages modulators
TargetsIntegrin alpha-M
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCase Western Reserve University School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesCase Western Reserve University School of Medicine
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A